BBL DrySlide Oxidase Kit — Class II medical device recall Z-1423-2013
Terminated recall by Becton Dickinson & Co., reported 2013-06-05, distributed nationwide. In-vitro diagnostic agents were placed into incorrect packaging for distribution to microbiological laboratori
| Recall number | Z-1423-2013 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Becton Dickinson & Co., Sparks, MD, United States |
| Recall initiated | 2013-04-12 |
| Classified | 2013-05-28 |
| Reported by FDA | 2013-06-05 |
| Terminated | 2013-09-28 |
| Distributed | Nationwide (US) |
| Countries outside the US | AU, CA, HK, MX, NZ, SG, TW |
| Quantity | 610 test |
| Reason classes | microbial contamination |
| Lot numbers | 2222008 |
| Model numbers | 231746 |
| Expiration dates | 2013-08-31 |
Product
BBL DrySlide Oxidase Kit, catalog number 231746 Product Usage: Presumptive diagnostic aid for gram-negative bacteria.
Reason for recall
In-vitro diagnostic agents were placed into incorrect packaging for distribution to microbiological laboratories.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1423-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.